The Lennox-Lombroso Pediatric Epilepsy Conference

The Lennox-Lombroso Pediatric Epilepsy Conference Banner

Date & Location
Friday, February 2, 2018 7:00 AM - Saturday, February 3, 2018 5:00 PM   Hilton Boston Back Bay, Boston, MA

Target Audience

A History of Innovation & Quality Care

Boston Children’s Hospital has been at the forefront of pediatric epilepsy research and care since the founding of the first comprehensive pediatric epilepsy treatment unit in 1944 by Dr. William Lennox.

In 1962, Dr. Cesare Lombroso succeeded Dr. Lennox as Chief of the Seizure Unit and EEG Laboratory at Boston Children’s, a position he held until 1988. Both of these physicians believed that the best results in children with seizures are achieved in a center that addresses simultaneously the medical, psychosocial, behavioral and family issues that impact their lives.  With this focus, the Seizure Unit at Boston Children’s Hospital grew to be a preeminent center for both treatment and clinical investigation.

State-of-the-art Education: The Lennox-Lombroso Pediatric Epilepsy Conference

The inaugural Lennox-Lombroso Pediatric Epilepsy Conference extends Boston Children’s tradition of excellence in continuing medical education to the field of childhood epilepsy diagnosis, management, and research. The course will cover a variety of topics including medical advances, discoveries and innovative technological approaches in epilepsy genetics, neurocritical care, computational neurophysiology, surgical procedures, and EEG ontogeny.

In addition to presenting the latest advances and innovations in epilepsy research and care, the course will provide the practitioner with clear guides in terms of how to apply knowledge in all domains of pediatric epilepsy. Core faculty are from the Division of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital, and invited faculty have been selected to highlight and honor faculty alumni who continue to make great contributions to the field, including keynote speakers Gregory L. Holmes MD, successor to Dr. Lombroso and current Chair of Neuroscience at the University of Vermont; Mohamad Mikati MD, Chief of Pediatric Neurology at Duke University; and James J. Riviello, Jr. MD, Professor of Pediatric Neurology and Developmental Neuroscience at Baylor College of Medicine.

Online Education | Epilepsy: New Concepts and Challenges

All attendees of the Lennox-Lombroso Epilepsy Conference will also have complimentary access to the online CME course Epilepsy: New Concepts and Challenges. In the self-guided online learning path, course director, Phillip Pearl, MD, discusses the latest approaches to evaluating, diagnosing and treating children with Epilepsy. For instructions on how to access the complimentary course, scroll down to the registration section on this page

Course Directors

  • Phillip L. Pearl, MD
  • Arnold J. Sansevere, MD 

Target Audience 

This course is designed to meet the educational needs of physicians, clinician-scientists, physician assistants, nurses, nurse practitioners, psychologists, allied health professionals, residents and fellows who specialize or have an interest in: 

  • pediatric neurology
  • neurology
  • pediatric epileptology
  • epilepsy and clinical neurophysiology
  • neuropsychology 
  • primary care 

This course is also open to any patients, families, and advocates that wish to attend. 

Upon completion of this course, participants will be able to:
  1. recognize the effects of seizures and spikes on the developing brain
  2. identify high risk populations for seizures in the critical care unit and apply standardized EEG interpretation
  3. select patients for epilepsy surgery including the rationale for different forms of invasive monitoring and technical approaches
  4. identify the correct genetic test and translational opportunity for selected patients depending upon the clinical presentation
  • Physicians (early bird rate-ends 11/30/17): $500.00
  • Physicians (regular rate): $550.00 
  • Allied Health Professionals: $300.00
  • Trainees: $300.00
  • Patients, Families, and Advocates: $300.00 

Registration includes complimentary access to the online CME Course: Epilepsy: New Concepts and Challenges.

Online Course Access

  • Existing OPENPediatrics users: If you have taken an online course on OPENPediatrics in the past OR have an existing OPENPediatrics account, you will be granted access to the online course within 3-5 business days of enrollment in the Lennox-Lombroso Pediatric Epilepsy Conference. 
  • First time OPENPediatrics users: You will need to create an account on OPENPediatrics before we can give you access to the course. To create an account, visit: and click “sign in/register” in the top right hand corner of the screen. Create a new account by clicking the “I want to create an account” button. Once you have successfully created an account, email for access to the course. 

Online Course FAQ/Troubleshooting

  • I have an account on CloudCME, does that mean I have an account on OPENPediatrics? Unfortunately, no. CloudCME and OPENPediatrics are two separate learning platforms that require two separate accounts. To make this easier on everyone, we suggest setting up your OPENPediatrics account with the same log in credentials as your cloudCME account if possible.  
  • I have an account on OPENPediatrics, but I can’t remember my password. Visit: and click “sign in/register”. Then Select “Request new Password”. Enter your username and email address and follow the prompts to reset your OPENPediatrics password. If you don’t see the forget password email come through in a few minutes, check your spam/junk folder. 

For additional questions or assistance, please contact the CME Department:

Refund policy

Registration by credit card can be made by clicking the register button above. Registration by check (draft on a United States bank): please make payable to Boston Children’s Hospital and contact the CME Department at to discuss payment. Telephone or fax registration is not accepted. Registration with cash payment is not permitted. Upon receipt of your paid registration, an email confirmation from the Boston Children’s office will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation and certificate.

Fifty-percent (50%) refunds will be issued for all cancellations received prior to the start of the course. Refund requests must be received by postal mail, email or telephone. “No shows” are subject to the full course fee, and no refunds will be issued once the conference has started.


In support of improving patient care, Boston Children's Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston Children’s Hospital designates this live activity for a maximum of  14.75 AMA PRA Category 1 Credits ™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.

AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.

Boston Children’s Hospital designates this activity for 14.75 contact hours for nurses. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure policy

Boston Children's Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CME activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children's may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.